Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease

ACS Chemical Neuroscience
Abdul Mannan Baig

Abstract

A loss of cholinergic neurons coupled with deposition of amyloid-beta (Aβ) has been implicated in the pathogenesis of Alzheimer's diseases (AD), but the exact point of origin of the cholinergic deficiency and Aβ deposition in the course of AD is yet to be established. Additionally, it remains to be recognized whether the cholinergic deficiency initiates the onset of AD or occurs in the midst of a yet unknown ongoing neuropathological process in AD. A comprehensive study of the pathogenic events, considering the etiology related biochemical deficits as the beginning point, which eventually leads to the accumulation of amyloid beta (Aβ) and tau tangles, is expected to clarify drug intervention points in AD. As clarity regarding the origins of Aβ and tau protein has now emerged, this Viewpoint highlights the link between the cholinergic deficits and Amyloid Precursor Protein (APP) formation in favor of amyloid beta (Aβ) as compared to the neuroprotective nonamyloidogenic secretory pathway of APP processing. A sustained muscarinic cholinergic receptor stimulation with specific drugs has been suggested with or without a concurrent anticholinesterase, which could discourage Aβ formation and accumulation early in the course of AD.

Citations

Jan 10, 2020·Journal of Biomolecular Structure & Dynamics·Mahesh Kumar TeliMi-Hyun Kim
Jul 15, 2020·Canadian Review of Sociology = Revue Canadienne De Sociologie·Xavier St-Denis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.